Overview

A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects

Status:
Completed

Trial end date:
2018-05-07

Target enrollment:

Participant gender:

Summary

This study will assess the PK similarity of epoetin administered as Hospira MDV versus Hospira SDV by conducting a single-dose comparative evaluation in normal healthy subjects enrolled at a single center.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Epoetin Alfa